Cara Therapeutics (NASDAQ:CARA) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Cara Therapeutics missed estimated earnings by 21.15%, reporting an EPS of $-0.63 versus an estimate of $-0.52.
Revenue was up $111.27 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.38 which was followed by a 5.28% increase in the share price the next day.
Here's a look at Cara Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.40 | -0.53 | -0.59 | 0.36 |
| EPS Actual | -0.02 | -0.61 | -0.47 | 1.59 |
| Revenue Estimate | 11.21M | 2.36M | 2.36M | 48.63M |
| Revenue Actual | 20.27M | 0 | 1.94M | 112.09M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
